() infections are notoriously complicated by the ability of the organism to grow in biofilms and are difficult to eradicate with antimicrobial therapy. The purpose of the current study was to clarify the influence of sub-inhibitory concentrations (sub-MICs) of daptomycin and tigecycline antibiotics on biofilm adhesion factors and exoproteins expressions by clinical isolates. Six clinical isolates representing positive biofilm clones (3 methicillin-sensitive (MSSA) and 3 methicillin-resistant (MRSA)) were grown with sub-MICs (0.5 MIC) of two antibiotics (daptomycin and tigecycline) for 12 h of incubation. RNA extracted from culture pellets was used via relative quantitative real-time-PCR (qRT-PCR) to determine expression of specific adhesion (, , , , , , , ) and biofilm () genes. To examine the effect of sub-MIC of these antibiotics on the expression of extracellular proteins, samples from the culture supernatants of six isolates were collected after 12 h of treatment with or without tigecycline in order to profile protein production via 2D gel sodium dodecyl sulfate-polyacrylamide gel electrophoresis (2D gel-SDS-PAGE). Sub-MIC treatment of all clinical MRSA and MSSA strains with daptomycin or tigecycline dramatically induced or suppressed , , , , , , , , and gene expression. Furthermore, sub-MIC use of tigecycline significantly reduced the total number of separated protein spots across all the isolates, as well as decreasing production of certain individual proteins. Collectively, this study showed very different responses in terms of both gene expression and protein secretion across the various isolates. In addition, our results suggest that sub-MIC usage of daptomycin and tigecycline could signal virulence induction by via the regulation of biofilm adhesion factor genes and exoproteins. If translating findings to the clinical treatment of , the therapeutic regimen should be adapted depending on antibiotic, the virulence factor and strain type.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7823975PMC
http://dx.doi.org/10.3390/antibiotics10010039DOI Listing

Publication Analysis

Top Keywords

daptomycin tigecycline
20
biofilm adhesion
8
clinical isolates
8
gene expression
8
tigecycline
7
daptomycin
5
isolates
5
role subinhibitory
4
subinhibitory concentrations
4
concentrations daptomycin
4

Similar Publications

Multicentre evaluation of in vitro activity of contezolid against drug-resistant Staphylococcus and Enterococcus.

J Antimicrob Chemother

December 2024

Department of Clinical Laboratory, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, No.1 Shuaifuyuan Wangfujing Dongcheng District, 100730, Beijing, China.

Article Synopsis
  • A multicenter study across 65 hospitals in China analyzed the effectiveness of contezolid against various strains of Staphylococcus and Enterococcus, focusing on its susceptibility and resistance patterns.
  • The research found that all strains were susceptible to contezolid, with low resistance rates to other antibiotics, notably finding higher linezolid resistance in Enterococcus faecalis than in Enterococcus faecium.
  • Results showed contezolid had a lower MIC50 compared to linezolid, indicating it may be a more effective option against resistant bacterial strains, particularly methicillin-resistant Staphylococcus and linezolid-resistant E. faecalis.
View Article and Find Full Text PDF

Background: Due to the increasing emergence of antibiotic resistance in Enterococcus faecalis (E. faecalis), it indicated as potentially opportunistic pathogen causing various healthcare-associated and life-threatening diseases around the world.

Objective: The aim of this meta-analysis was to evaluate the weighted pooled resistance rates in clinical E.

View Article and Find Full Text PDF

Objective: To analyze the antibiotic resistance profile, virulence genes, and molecular typing of () strains isolated in skin and soft tissue infections at the First Affiliated Hospital, Gannan Medical University, to better understand the molecular epidemiological characteristics of .

Methods: In 2023, 65 strains were isolated from patients with skin and soft tissue infections. Strain identification and susceptibility tests were performed using VITEK 2 and gram-positive bacteria identification cards.

View Article and Find Full Text PDF

Insights into the molecular basis of reduced vancomycin susceptibility among three prominent clonal complexes.

Microbiol Spectr

August 2024

Laboratory of Bacteriology, Rocky Mountain Laboratories, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana, USA.

Unlabelled: is a leading cause of healthcare-associated infections globally. Vancomycin-resistant (VRSA), those with high-level resistance [minimum inhibitory concentration (MIC) of 16-32 µg/mL vancomycin], are uncommon, whereas vancomycin-intermediate (VISA; MIC of 4-8 µg/mL), are isolated more frequently and develop during long-term and/or repeated use of the antibiotic. VISA can be difficult to eradicate and infections may persist.

View Article and Find Full Text PDF

Implementation of an Automated Antibiotic Time-out at a Comprehensive Cancer Center.

Open Forum Infect Dis

May 2024

Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Background: Antimicrobial stewardship programs can optimize antimicrobial use and have been federally mandated in all hospitals. However, best stewardship practices in immunocompromised patients with cancer are not well established.

Methods: An antimicrobial time out, in the form of an email, was sent to physicians caring for hospitalized patients reaching 5 days of therapy for targeted antimicrobials (daptomycin, linezolid, tigecycline, vancomycin, imipenem/cilastatin, meropenem) in a comprehensive cancer center.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!